An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT06032208

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06032208
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06032208. Allocation not applicable; no masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
Condition
End Stage Renal Disease
Intervention (Device)
Theranova Dialyzer
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (class: other)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct06032208
Content hash
496b38a7225eb440eeae2f4034eda0cfcdd7f2059b006c91c59c738152a75be0